• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Rite Aid Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8/24/23 4:05:27 PM ET
    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $RAD alert in real time by email
    0000084129 false 0000084129 2023-08-18 2023-08-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(D) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of report (Date of earliest event reported):
    August 18, 2023

     

    Rite Aid Corporation

    (Exact name of registrant as specified in its charter)

     

    Delaware   1-5742   23-1614034
    (State or Other Jurisdiction
    of Incorporation)
      (Commission File Number)   (IRS Employer
    Identification Number)

     

    P.O. Box 3165

    Harrisburg, Pennsylvania 17105

    (Address of principal executive offices, including zip code)

     

    (717) 761-2633

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which
    registered
    Common Stock, $1.00 par value   RAD   The New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company      ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 5.07.Submission of Matters to a Vote of Security Holders.

     

    Rite Aid Corporation (“Rite Aid”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”) on August 18, 2023. The following is a summary of the matters voted on at the Annual Meeting.

     

    (a) The stockholders elected Rite Aid’s nominees to the Board of Directors. The nominees to Rite Aid’s Board of Directors and the number of shares cast for, the number against, the number abstaining and broker non-votes, with respect to each of these persons, were as follows:

     

    Board Nominees

     

    Name  For   Against   Abstain   Broker Non-Votes 
    Bruce G. Bodaken   8,359,075    5,345,699    239,208    21,145,638 
    Elizabeth “Busy” Burr   9,697,011    3,966,285    280,686    21,145,638 
    Bari Harlam   8,978,317    4,620,666    344,999    21,145,638 
    Robert E. Knowling, Jr.   8,969,299    4,637,323    337,360    21,145,638 
    Arun Nayar   8,990,608    4,612,421    340,953    21,145,638 
    Kate B. Quinn   9,122,010    4,518,353    303,619    21,145,638 

     

    (b) The stockholders ratified the appointment of Deloitte & Touche LLP as Rite Aid’s independent registered public accounting firm. The number of shares cast in favor of the ratification of Deloitte & Touche LLP, the number against, the number abstaining and broker non-votes were as follows:

     

    For   Against   Abstain   Broker Non-Votes  
      27,418,162     7,307,491     363,967     0  

     

    (c) The stockholders approved, on an advisory basis, the compensation of Rite Aid’s Named Executive Officers as set forth in the Definitive Proxy Statement. The number of shares cast in favor of the compensation of Rite Aid’s Named Executive Officers, the number against, the number abstaining and broker non-votes were as follows:

     

    For   Against   Abstain   Broker Non-Votes  
      8,321,452     5,312,020     310,510     21,145,638  

     

    (d) The stockholders recommended, on an advisory basis, a one year frequency of future advisory votes to approve the compensation of Rite Aid's Named Executive Officers. The number of shares cast in favor of a one year frequency of future advisory votes, the number cast in favor of a two year frequency of future advisory votes, the number cast in favor of a three year frequency of future advisory votes, and the number abstaining were as follows:

     

    One Year  Two Years  Three Years  Abstain  Broker Non-Votes 
     11,591,333   423,902   1,213,450   715,297   21,145,638 

     

     

     

     

    Based upon the results of this vote, and consistent with the Board’s recommendation, Rite Aid has determined that it will hold an advisory "say-on-pay" vote every year in connection with its annual meeting of stockholders until the next stockholder vote on the frequency of "say-on-pay" votes.

     

    (e) The stockholders did not approve the amendments to the Rite Aid Corporation Amended and Restated Certificate of Incorporation to eliminate the supermajority voting provisions contained therein as set forth in the Definitive Proxy Statement. The number of shares cast in favor of the adoption of the amendment, the number against, the number abstaining and broker non-votes were as follows:

     

    For   Against   Abstain   Broker Non-Votes  
      9,821,811     3,830,703     291,468     21,145,638  

     

    (f) The stockholders did not approve a stockholder proposal to require an annual advisory vote on the compensation of Rite Aid's directors. The number of shares cast in favor of the stockholder proposal, the number against, the number abstaining and broker non-votes were as follows:

     

    For  Against  Abstain  Broker Non-Votes 
     5,702,261   8,047,833   193,888   21,145,638 

     

    (g) The stockholders approved a stockholder proposal to adopt an executive compensation adjustment policy. The number of shares cast in favor of the stockholder proposal, the number against, the number abstaining and broker non-votes were as follows:

     

    For  Against  Abstain  Broker Non-Votes 
     7,280,435   6,455,280   208,267   21,145,638 

     

    (h) The stockholders did not approve a stockholder proposal, introduced from the floor by Mr. Steven Krol, requesting that the Board of Directors take the steps necessary to amend Rite Aid's governance documents to give stockholders of record and beneficial stockholders an equal right to call for a special meeting of stockholders so long as they hold at least 10% of Rite Aid's stock. The inspector of election applied the discretionary authority of the proxy holders with respect to registered shares (but not “street name” shares), and accordingly reported that 94,179 shares cast votes in favor of the stockholder proposal and 320,759 shares cast votes against the proposal.  Applying the discretionary authority of the proxy holders to all registered shares and to shares held in “street name” providing voting instructions, the number of shares cast in favor of the stockholder proposal, the number against, the number abstaining and broker non-votes were as follows:
       

    For  Against  Abstain  Broker Non-Votes 
     94,179   13,849,803   0   21,145,638 

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

     

    Date: August 24, 2023 By: /s/ Matthew C. Schroeder
      Name: Matthew C. Schroeder
      Title: Executive Vice President and Chief Financial Officer

     

     

     

    Get the next $RAD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RAD

    DatePrice TargetRatingAnalyst
    4/7/2022$16.00 → $1.00Hold → Sell
    Deutsche Bank
    6/25/2021$21.00 → $12.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $RAD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Rite Aid downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Rite Aid from Hold to Sell and set a new price target of $1.00 from $16.00 previously

      4/7/22 7:32:45 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid downgraded by JP Morgan with a new price target

      JP Morgan downgraded Rite Aid from Neutral to Underweight and set a new price target of $12.00 from $21.00 previously

      6/25/21 7:27:02 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Deutsche Bank reiterated coverage on Rite Aid with a new price target

      Deutsche Bank reiterated coverage of Rite Aid with a rating of Hold and set a new price target of $27.00 from $17.00 previously

      3/25/21 9:26:08 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAD
    Leadership Updates

    Live Leadership Updates

    See more
    • Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer

      Stein Succeeds Elizabeth "Busy" Burr Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately. Mr. Stein succeeds Elizabeth ("Busy") Burr, who has served as Interim CEO of Rite Aid since January 2023. Ms. Burr will continue to serve on the Company's Board. Mr. Stein brings more than three decades of experience as a leader and executive director at both public and private companies. Mr. Stein has particular expertise in supporting companies that are driving meaningful business tran

      10/15/23 10:37:00 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success

      Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment for $3.45 Billion in New Financing to Support Business Operations Continuing to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") today announced it has reached an agreement in principle with certain of its senior secured noteholders on the terms of a financial restructuring plan that will allow the Co

      10/15/23 10:37:00 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Carenet Health Acquiring Health Dialog, Enhancing Clinical Team and Advancing Insights-Driven Platform Dedicated to the Business of Healthcare

      Expanded personalized population health capabilities support better health journeys for patients Carenet Health, a trusted partner in helping organizations simplify and power the business of healthcare, is excited to announce it is acquiring Health Dialog, a worldwide leader in delivering clinical decision support offerings. This acquisition enables Carenet to leverage its combined platform, analytics and clinicians to deliver greater efficiency and outcomes-based financial performance for clients. Health Dialog provides personalized population health services to health plans, providers, employers and pharmaceutical manufacturers. Carenet is acquiring all assets of Health Dialog from

      3/6/24 11:05:00 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Receives Court Approval of "First Day" Motions to Support Business Operations

      Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC:RADCQ) ("Rite Aid" or the "Company") today announced that it has received approvals from the U.S. Bankruptcy Court for the District of New Jersey for its "First Day" motions related to the Company's voluntary Chapter 11 petitions filed on October 15, 2023. The Court granted interim approval to access up to $3.45 billion in debtor-in-possession financing from certain of its lenders. This financing is expected to provide sufficient liquidity to support the Company th

      10/17/23 11:05:00 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer

      Stein Succeeds Elizabeth "Busy" Burr Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately. Mr. Stein succeeds Elizabeth ("Busy") Burr, who has served as Interim CEO of Rite Aid since January 2023. Ms. Burr will continue to serve on the Company's Board. Mr. Stein brings more than three decades of experience as a leader and executive director at both public and private companies. Mr. Stein has particular expertise in supporting companies that are driving meaningful business tran

      10/15/23 10:37:00 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAD
    SEC Filings

    See more

    $RAD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $RAD
    Financials

    Live finance-specific insights

    See more
    • SEC Form NT 10-Q filed by Rite Aid Corporation

      NT 10-Q - RITE AID CORP (0000084129) (Filer)

      1/12/24 5:00:11 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits

      8-K - RITE AID CORP (0000084129) (Filer)

      12/27/23 6:03:09 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - RITE AID CORP (0000084129) (Filer)

      11/1/23 4:30:23 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by Rite Aid Corporation (Amendment)

      SC 13G/A - RITE AID CORP (0000084129) (Subject)

      2/9/23 11:32:52 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by Rite Aid Corporation (Amendment)

      SC 13G/A - RITE AID CORP (0000084129) (Subject)

      7/11/22 1:13:14 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by Rite Aid Corporation (Amendment)

      SC 13G/A - RITE AID CORP (0000084129) (Subject)

      3/9/22 8:44:09 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation Reports Fiscal 2024 First Quarter Results

      Revenues of $5.7 Billion, Compared to Prior Year Revenues of $6.0 Billion Retail Comparable Same Store Prescriptions Increased 4.7 Percent – Comparable Same Store Prescriptions, Excluding COVID Impact, Increased 7.4 Percent Net Loss of $306.7 Million Compared to Prior Year Net Loss of $110.2 Million – Increase Largely Attributable to a Goodwill Impairment Charge at Elixir Adjusted EBITDA of $91.7 Million, Compared to Prior Year Adjusted EBITDA of $100.1 Million Updates Fiscal 2024 Outlook Rite Aid Corporation (NYSE:RAD) today reported operating results for its first fiscal quarter ended June 3, 2023. "Our first quarter results were driven by strong script growth, solid ph

      6/29/23 7:00:00 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid to Release First Quarter Results on June 29

      Rite Aid Corporation (NYSE:RAD) will release financial results for its Fiscal 2024 First Quarter, which ended June 3, 2023, on Thursday, June 29, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. ET on Thursday, June 29, 2023, through 11:59 p.m. ET on July 29, 2023. To access the replay of the call, please dial (800) 770-2030 or (647) 362-9199 and enter the seven-digit reservation number 9029129. The webcast replay of the call will also be available at https://investors.riteaid.com starting at 12 p.m. ET Thursda

      6/12/23 8:30:00 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation Reports Fiscal 2023 Fourth Quarter and Full Year Results and Provides Fiscal 2024 Outlook

      Fourth Quarter Highlights: Revenues of $6.1 billion, Comparable to Prior Year Retail Comparable Same Store Prescriptions Increased 5.2 Percent – Comparable Same Store Prescriptions, Excluding COVID Impacts, Increased 9.7 Percent Net Loss per Share of $4.39, Compared to Prior Year Net Loss per Share of $7.18 Adjusted EBITDA of $128.6 million, Compared to the Prior Year Adjusted EBITDA of $106.1 million Completed Tender Offer for $165 million of our 2025 notes – Reducing Amount Outstanding to $320 million From $600 million at Beginning of Fiscal 2022 Full Year Highlights: Revenues of $24.1 billion, Compared to Prior Year Revenues of $24.6 billion Retail Comparable Same

      4/20/23 7:00:00 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3: New insider Dupaul Christopher W. claimed ownership of 34,525 shares

      3 - RITE AID CORP (0000084129) (Issuer)

      8/24/23 4:33:34 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 4 filed by Schroeder Matt

      4 - RITE AID CORP (0000084129) (Issuer)

      7/28/23 4:10:16 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 4 filed by Mennen Justin L.

      4 - RITE AID CORP (0000084129) (Issuer)

      7/28/23 4:09:48 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples